Who makes Oshadi Oral Insulin?

Oshadi Oral Insulin is developed by Oshadi Drug Administration.

What development phase is Oshadi Oral Insulin in?

Oshadi Oral Insulin is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Oshadi Oral Insulin

Oshadi Drug Administration · Phase 1 active Small molecule

At a glance

Generic name	Oshadi Oral Insulin
Sponsor	Oshadi Drug Administration
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study (PHASE2)
Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study (PHASE1, PHASE2)
Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oshadi Oral Insulin CI brief — competitive landscape report
Oshadi Oral Insulin updates RSS · CI watch RSS
Oshadi Drug Administration portfolio CI